Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP169862.RAqTit2L3B7eCAjVoX7IVXbeA5rTliPgL_kpbb3MuwSPo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP169862.RAqTit2L3B7eCAjVoX7IVXbeA5rTliPgL_kpbb3MuwSPo130_assertion type Assertion NP169862.RAqTit2L3B7eCAjVoX7IVXbeA5rTliPgL_kpbb3MuwSPo130_head.
- NP169862.RAqTit2L3B7eCAjVoX7IVXbeA5rTliPgL_kpbb3MuwSPo130_assertion wasGeneratedBy ECO_0000203 NP169862.RAqTit2L3B7eCAjVoX7IVXbeA5rTliPgL_kpbb3MuwSPo130_provenance.
- NP169862.RAqTit2L3B7eCAjVoX7IVXbeA5rTliPgL_kpbb3MuwSPo130_assertion wasDerivedFrom befree-20140225 NP169862.RAqTit2L3B7eCAjVoX7IVXbeA5rTliPgL_kpbb3MuwSPo130_provenance.
- NP169862.RAqTit2L3B7eCAjVoX7IVXbeA5rTliPgL_kpbb3MuwSPo130_assertion SIO_000772 22157961 NP169862.RAqTit2L3B7eCAjVoX7IVXbeA5rTliPgL_kpbb3MuwSPo130_provenance.
- NP169862.RAqTit2L3B7eCAjVoX7IVXbeA5rTliPgL_kpbb3MuwSPo130_assertion evidence source_evidence_literature NP169862.RAqTit2L3B7eCAjVoX7IVXbeA5rTliPgL_kpbb3MuwSPo130_provenance.
- NP169862.RAqTit2L3B7eCAjVoX7IVXbeA5rTliPgL_kpbb3MuwSPo130_assertion description "[The malignancy-risk gene signature could be useful to improve prediction of OS and to identify those NSCLC patients who will benefit from ACT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP169862.RAqTit2L3B7eCAjVoX7IVXbeA5rTliPgL_kpbb3MuwSPo130_provenance.